Coronavirus
In the context of supply issues, the African Union has abandoned plans to procure coronavirus vaccines from the Serum Institute in India and is now discussing possibilities with the U.S. Johnson & Johnson.
John Nkengasong, head of the African Disease Control Centers, said the sufficient supply of vaccine was crucial – and that export constraints by India is problematic for Africa.
He went on to say that the AU's decision had nothing to do with the potential connection to blood clots in some rare cases surrounding the Oxford-AstraZeneca vaccine.
He stressed that the AstraZeneca vaccine will still be distributed to Africa through the UN's Covax program.
Nkengasong claimed that the AU had already signed a contract with Johnson & Johnson for up to 400 million single dose vaccines.
01:15
Africa: About 51 million lives saved through immunization programme - WHO
01:13
WHO approves new cholera vaccine that could help fight surge in cases
00:54
African issues to be discussed as foreign ministers of G7 countries meet
01:08
Moderna puts Kenya plant plans on hold
01:11
Malaria: Africa's most affected countries commit to end deaths
01:12
Is Rwanda opposed to an AU-backed SADC operation in eastern DRC?